Arbutus Biopharma Corporation (Nasdaq: ABUS) is a clinical-stage biopharmaceutical company focused on infectious disease. We are currently developing imdusiran (AB-729), our proprietary, GalNAc-conjugated, subcutaneously-delivered ribonucleic acid interference (RNAi) therapeutic, and AB-101, our proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B virus.
Looking for a particular Arbutus Biopharma Corporation employee's phone or email?
Arbutus Biopharma Corporation Questions
The Arbutus Biopharma Corporation annual revenue was $13 million in 2026.
Tuan Nguyen is the CFO of Arbutus Biopharma Corporation.
62 people are employed at Arbutus Biopharma Corporation.
Arbutus Biopharma Corporation is based in Warminster, Pennsylvania.
The NAICS codes for Arbutus Biopharma Corporation are [5417, 541714, 3254, 325, 32, 54, 541, 54171].
The SIC codes for Arbutus Biopharma Corporation are [873, 87].
Top Arbutus Biopharma Corporation Employees
-
Lindsay Androski
Special Counsel at Arbutus Biopharma Corporation
Washington, DC, US34 -
Tuan Nguyen
Chief Financial Officer at Arbutus Biopharma Corporation
San Francisco, CA, US24 -
41
-
Andrew Cole
Vice President, Chemistry at Arbutus Biopharma Corporation
Warminster, PA, US35+ -
25+
-
Laura Hathaway
VP Controller at Arbutus Biopharma Corporation
San Francisco, CA, US22
Related Companies
